Scrip
US buys 10,000 courses of BioCryst's peramivir
06 November 2009
Sue Sutter
Please Login to read the full article.
06 November 2009
Sue Sutter
BioCryst Pharmaceuticals has shipped 10,000 treatment courses of its intravenous antiviral peramivir to the US health and human services (HHS) department under a $22.5 million contract aimed at countering the toll of H1N1 influenza.
The order came less than two weeks after the FDA authorised...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Interview: European Medicines Agency gets serious about its global strategy
- Dr Jonathan Knowles: Roche's passionate visionary
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
